- Alternative title
-
Gezielte Proteindegradation in der Pathogenese und Therapie des Multiplen Myeloms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Dissertation, 2025
- Keyword
-
Targeted drug delivery
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (when)
-
2025
- Creator
-
Ng, Yuen Lam Dora
- DOI
-
10.17169/refubium-45716
- URN
-
urn:nbn:de:kobv:188-refubium-46006-6
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ng, Yuen Lam Dora
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Time of origin
- 2025
Other Objects (12)
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
BCMA-targeted immunotherapy for multiple myeloma
Multiple myeloma: signaling pathways and targeted therapy
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Multiple myeloma
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
The role of JunB in multiple myeloma pathogenesis: focus on angiogenesis
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
BCMA-targeted immunotherapy for multiple myeloma
Multiple myeloma: signaling pathways and targeted therapy
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Multiple myeloma
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
The role of JunB in multiple myeloma pathogenesis: focus on angiogenesis
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
Multiple Myeloma: Molecular Pathogenesis and Disease Evolution
BCMA-targeted immunotherapy for multiple myeloma
Multiple myeloma: signaling pathways and targeted therapy
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
Pathogenesis of bone disease in multiple myeloma: from bench to bedside
Targeted immunotherapy: harnessing the immune system to battle multiple myeloma
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Multiple myeloma
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
The role of JunB in multiple myeloma pathogenesis: focus on angiogenesis
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis